Abbott has returned for the first close of insulin technology developer Bigfoot Biomedical’s series C round, after backing its $55m series B two years ago.

Spectrum Health and HCA Healthcare both scored exits after medical analytics software provider Lumere was acquired by health software producer GHX.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Antiviral drug maker Gilead is among the investors that have backed the cell therapy startup’s $25m round.

Zipari has raised $22.5m from Horizon Healthcare Services and CareFirst BlueCross BlueShield among others to boost its total to $33.9m.

JSR Life Sciences and its KBI Biopharma unit co-led a $10.4m round for AbSci and have picked up global marketing rights for the biomanufacturing company's forthcoming product launch.

Subsidiaries of Astellas and Novartis co-led a series B round that took Harvard's cancer treatment developer's overall funding to $60m.

Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.

Fusion Pharmaceuticals has now raised $171m altogether to deliver cancer radiopharmaceuticals based on McMaster University research.

GV and Nextech are among the participants in a series A round that is funding the launch of EQRx, which is developing cheaper copies of existing drugs.